Nephrogenic fibrosing dermopathy classification
|
Nephrogenic fibrosing dermopathy Microchapters |
|
Differentiating Nephrogenic fibrosing dermopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nephrogenic fibrosing dermopathy classification On the Web |
|
American Roentgen Ray Society Images of Nephrogenic fibrosing dermopathy classification |
|
Directions to Hospitals Treating Nephrogenic fibrosing dermopathy |
|
Risk calculators and risk factors for Nephrogenic fibrosing dermopathy classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Classification
The European authorities have classified the gadolinium-containing contrast agents in three groups:[1]
- Least likely (safest) to release free gadolinium ions Gd3+ in the body have a cyclical structure: Dotarem, Gadovist and ProHance
- Intermediate have a ionic linear structure: Magnevist, MultiHance, Primovist and Vasovist
- Most likely to release Gd3+ have a linear non-ionic structure: Omniscan and OptiMARK
It can be noted that this classification was released after another proposition would have left the safest category (ionic cyclical structure) with only one agent (Dotarem). The intermediate category would have been either ionic linear structure or non-ionic cyclical structure. The third category most at risk was unchanged (linear non-ionic).[2]